Cleo Crunelle

Cleo Crunelle is a Researcher in Toxicology at the University of Antwerp, focusing on substance-related disorders, ADHD, and alcohol abuse. Her work integrates clinical research with biomarker analysis and neuromodulation therapies. She leads projects like the ADORE initiative examining ADHD medication in pregnancy and the FOD109 study on outcome measurements in addiction services. Key collaborations include the PRISM mental health network and the IOF GEAR AI initiative in neurology/psychiatry.

Research interests span ethyl glucuronide biomarkers, opioid detoxification, and transcranial stimulation for addiction. She has published over 150 peer-reviewed articles and supervised 9 theses. Media engagements include expert commentary on ADHD treatment and alcohol's impact on youth brains.